EUVIMEDEUVIMED entdecken
Crossref

A Modified Polydopamine Nanoparticle Loaded with Melatonin for Synergistic ROS Scavenging and Anti‐Inflammatory Effects in the Treatment of Dry Eye Disease

Xue Yang, Bowen Wang, Hao Zeng, Lihong Liang, Runze Zhang, Wenrui Deng, Xuan Zhao, Jin Yuan iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Xue Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Sun Yat-sen …. Hauptthemen laut MEDLINE: Indoles, Polymers, Nanoparticles, Melatonin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a multifaceted ocular surface disorder that significantly impacts patients’ daily lives and imposes a substantial economic burden on society. Oxidative stress, induced by the overproduction of reactive oxygen species (ROS), is a critical factor perpetuating the inflammatory cycle in DED. Effectively scavenging ROS is essential to impede the progression of DED. In this study, boronophenylalanine‐ containing polydopamine (PDA‐PBA) nanoparticles are developed loaded with melatonin (MT), which are blended with poly(vinyl alcohol) (PVA) to create eye drops PVA/ PDA‐PBA@MT (PPP@MT). In vitro and in vivo studies demonstrate that PPP@MT exhibits dual functionalities in reducing ROS production and downregulating inflammatory pathways, thereby preserving mitochondrial integrity and further inhibiting programmed cell death. Following PPP@MT treatment, tear secretion, corneal structure, and the number of goblet cells are markedly restored in a mouse model of dry eye, indicating the therapeutic efficacy of this agent. Collectively, PPP@MT, characterized by minimal side effects and favorable bioavailability, offers promising therapeutic insights for the management of DED and other ROS‐mediated disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesPolymersNanoparticlesMelatoninDry Eye SyndromesReactive Oxygen SpeciesAnti-Inflammatory AgentsAnimalsMiceHumansDisease Models, AnimalPolyvinyl AlcoholOxidative Stress

Stichwörter der Autor:innen

dry eye diseasemelatoninnanoparticleoxidative stresspolydopamine

Substanzen

polydopamineIndolesPolymersMelatoninReactive Oxygen SpeciesAnti-Inflammatory AgentsPolyvinyl Alcohol

Autor:innen und Institutionen

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.
  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing, 100730, China.

ORCID-Profile: Jin Yuan

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Yang, X., Wang, B., Zeng, H., Liang, L., Zhang, R., Deng, W., Zhao, X., & Yuan, J. (2025). A Modified Polydopamine Nanoparticle Loaded with Melatonin for Synergistic ROS Scavenging and Anti‐Inflammatory Effects in the Treatment of Dry Eye Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404372

Vancouver

Yang X, Wang B, Zeng H, Liang L, Zhang R, Deng W, et al. A Modified Polydopamine Nanoparticle Loaded with Melatonin for Synergistic ROS Scavenging and Anti‐Inflammatory Effects in the Treatment of Dry Eye Disease. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404372

BibTeX
@article{Yang2025,
  author = {Yang, Xue and Wang, Bowen and Zeng, Hao and Liang, Lihong and Zhang, Runze and Deng, Wenrui and Zhao, Xuan and Yuan, Jin},
  title = {A Modified Polydopamine Nanoparticle Loaded with Melatonin for Synergistic ROS Scavenging and Anti‐Inflammatory Effects in the Treatment of Dry Eye Disease},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404372}
}
Kostenlos starten →